Salus Thomas D. 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Apr 16, 2025
Insider Transaction Report
Form 4
Salus Thomas D.
Chief Legal & Administration
Transactions
- Award
Performance-Based Restricted Stock Units
2025-04-14+370,000→ 0 totalExp: 2030-04-14→ Common Stock (370,000 underlying) - Award
Common Stock
2025-04-14+170,000→ 215,000 total - Award
Incentive Stock Option (Right to Buy)
2025-04-14+210,000→ 210,000 totalExercise: $6.17From: 2026-04-14Exp: 2032-04-14→ Common Stock (210,000 underlying) - Award
Common Stock
2025-04-14+45,000→ 45,000 total
Footnotes (4)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.
- [F4]The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock prices.